Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Research and Clinical Diagnostic Tests and Controls
  4. Point of Care Testing
  5. 21402724

Lumos Diagnostics FebriDx™ Bacterial / Non-Bacterial Point-of-Care Assay

Catalog No. 21402724
Change view
Click to view available options
:
Test Kit
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No.
21-402-724 Test Kit
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 21-402-724 Supplier Lumos Diagnostics Supplier No. CP0014
This item is not returnable. View return policy

Description

FebriDx is a rapid point-of-care test that uses a fingerstick blood sample to aid in the differentiation between bacterial infection and non-bacterial etiology.

  • FebriDx is a rapid point-of-care test that uses a fingerstick blood sample to aid in the differentiation between bacterial infection and non-bacterial etiology.
  • FebriDx is intended to be used in urgent and emergency care settings.Knowing whether a patient has a bacterial infection has a direct impact on reducing unnecessary antibiotic prescriptions, limiting the spread of antibiotic-resistant bacteria, and helping providers know when to initiate treatment.
  • Results after 10 minutes increases confidence in whether or not to prescribe an antibiotic.
  • Highly sensitive/specific dual biomarker technology provides reliable differentiation of bacterial and non-bacterial infections.
  • All-in-one, instrument-free test device means no expensive equipment and a fully portable solution. Increase confidence in decision making.
  • Confidently rule out a bacterial infection with 99% negative predictive value (NPV).
  • Ensure bacterial infections are not overlooked.
  • Increased confidence in patient diagnosis.
  • Improve patient satisfaction.
  • Support patient understanding of treatment plan with a tangible test result.
  • Enable improved patient management.
  • Actionable results after 10 minutes for use during a patient visit.
  • Support antimicrobial stewardship.
  • Reduce unnecessary antibiotic use.

Specifications

CE Marker No
Clia Complexity Moderate
Detectable Analytes Influenza A and Influenza B Nucleoprotein Antigens
Type Point-of-Care Assay
Disposable Single-use
Form Ready-to-Use (RTU)
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.